The selection of propylene glycol for oral and topical pharmaceutical manufacturing is governed by compendial monograph compliance, supplier qualification against ethylene glycol and diethylene glycol adulteration, and process-specific control of hygroscopicity and oxidative degradation. Monograph-grade material conforming to USP-NF, Ph. Eur., and JP is not a single chemical entity but a defined purity envelope in which specific gravity at 25°C falls between 1.035 and 1.037, refractive index at 20°C falls between 1.431 and 1.433, water content is held at or below 0.2%, and ethylene glycol and diethylene glycol are each controlled at or below 0.1%. These limits, measured by oscillating U-tube densitometry, Abbe refractometry, Karl Fischer titration, and capillary gas chromatography with flame-ionisation detection, directly affect oral solution clarity, softgel shell plasticity, topical cream gloss, and patient safety. A supply chain receiving technical-grade propylene glycol without these controls introduces the specific risk of diethylene glycol poisoning, which historically led to multiple fatal incidents after substitution into oral liquid vehicles. The sections that follow address those selection boundaries with reference to pharmacopoeial test methods, production-scale equipment behaviour, and the processing thresholds at which propylene glycol shifts from inert excipient to a source of water uptake, carbonyl impurity, or plasticizer incompatibility.

What Distinguishes Monograph-Grade Propylene Glycol from Technical-Grade Feedstock at Incoming Release?

At incoming release, the distinction is confirmed not by supplier certificate alone but by the compression of several orthogonal analytical tests into a single release decision. Specific gravity is measured under USP <841> and must fall between 1.035 and 1.037 at 25°C for USP-NF material, while the Ph. Eur. monograph permits a slightly wider relative density of 1.035–1.040. Refractive index is measured under USP <831> and must fall between 1.431 and 1.433 at 20°C, with the Ph. Eur. and JP specifications allowing 1.431–1.434. Water content is controlled at ≤0.2% by USP <921> Method Ia or Method Ic, using a Karl Fischer titrator equipped with a generator electrode and an oven sample processor to minimise matrix interference. The two safety-critical impurities, ethylene glycol and diethylene glycol, are each limited to ≤0.1% and are determined by gas chromatography with flame-ionisation detection using a polar capillary column, a dilute methanolic sample preparation, and an inlet temperature sufficient to volatilise both diols without thermal degradation. Assay is typically controlled at ≥99.5% by gas chromatography or an equivalent compendial method. Gross adulteration with glycerin or sorbitol solution can be detected by density and refractive index shifts, but low-level diethylene glycol contamination cannot be reliably excluded by these physical constants alone; only chromatographic separation resolves ethylene glycol and diethylene glycol from propylene glycol with sufficient detection sensitivity. The pharmacopoeial release limits therefore function as a safety gate, while the physical constants function as rapid identity and gross-purity checks during sampling.

The incoming release laboratory should also retain a reference sample from every bulk receiving vessel because the retrospective identification of diethylene glycol adulteration has required re-analysis of retained samples from multiple manufacturing campaigns. Where regional monographs still list heavy metals as a colorimetric limit of ≤5 ppm, the result is typically supplemented by a site-level elemental impurity risk assessment under ICH Q3D; the compendial test alone is not a substitute for a supply-chain risk assessment when redistilled or recovered material may be offered. Bulk containers should be dedicated stainless steel or lined epoxy phenolic drums with tamper-evident seals, and the unloading line should be filtered through a 0.45 μm polypropylene capsule before the material enters the quarantine tank.

Propylene glycol is hygroscopic across the upper range of storage relative humidity, and the resulting water absorption alters both its density and its behaviour as a co-solvent in aqueous oral vehicles. At 20°C and relative humidity above 60%, open stainless steel 316L storage vessels with simple vent filters can take up atmospheric moisture at rates sufficient to shift water content by 0.1–0.3% w/w over 24 h depending on surface-to-volume ratio and air turnover. The moisture sorption isotherm of propylene glycol is highly temperature-dependent; at 25°C the equilibrium water content remains below 0.2% only when the surrounding air is maintained below roughly 50–60% RH, and above this threshold the liquid acts as a humectant rather than an inert solvent. This boundary becomes operationally critical in tropical manufacturing sites where warehouse relative humidity may exceed 75%; transfer lines and receiving tanks should therefore be blanketed with pharmaceutical-grade nitrogen at 0.2–0.5 bar positive pressure and fitted with silica gel or molecular sieve vent dryers. In oral granulation, water absorbed into propylene glycol during hold times can reduce batch-to-batch reproducibility of granule size distribution in fluid-bed granulators with a defined air inlet dew point of 8°C; if the dew point is not controlled, the quantity of added water in the binder solution must be corrected using Karl Fischer data taken within 2 h of use. For topical anhydrous bases, absorbed water can lower the thermodynamic activity of moisturising systems but also destabilise water-in-oil emulsions; therefore bulk propylene glycol for anhydrous topicals should be discharged under dry nitrogen and transferred through polished stainless steel lines with Ra ≤0.8 μm to reduce condensate retention.

Thermal Degradation Pathways in Aqueous Propylene Glycol Vehicles Differ from Those in Anhydrous Topical Bases

In aqueous liquid manufacturing, propylene glycol is typically exposed to temperatures of 60–80°C during compounding of oral syrups and topical gels, well below its normal boiling point of 188°C but sufficient to accelerate oxidation when dissolved oxygen and trace transition metals are present. The primary degradation pathway proceeds through radical-mediated oxidation at the secondary alcohol group, yielding hydroxyacetone, lactaldehyde, and subsequently lactic and acetic acids; this acid formation is detectable as downward pH drift in unbuffered vehicles and can interact with acid-labile actives such as clavulanate or certain statins. Closed stainless steel mixing vessels with nitrogen overlay and dissolved oxygen levels below 0.5 mg/L are therefore specified for high-shear processing at temperatures above 60°C, particularly when the batch is held for longer than 4 h. In anhydrous topical bases prepared by hot-melt addition of propylene glycol to fatty alcohols and petrolatum, the absence of water lowers hydrolysis but can increase peroxide formation if air is entrained in the molten phase; at heating temperatures above 70°C, the use of vacuum-emulsification equipment with a residual pressure of −0.8 bar and rotor-stator homogenisation below 800 rpm limits aeration but does not eliminate the need for an antioxidant such as butylated hydroxytoluene at 0.01–0.05% w/w of the lipid phase. Oxidation products can be monitored by peroxide value according to Ph. Eur. 2.5.5 and acid value according to Ph. Eur. 2.5.1, with typical rejection limits for pharmaceutical topical bases set at peroxide value ≤10 meq/kg and acid value ≤2 mg KOH/g. Published data for specific propylene glycol degradation rates in multi-component oral vehicles is limited; therefore each site should validate maximum holding time at the highest processing temperature rather than relying on bulk stability data generated under ambient storage.

Propylene glycol in oral liquids functions not as an inert diluent but as a water-miscible co-solvent that raises the saturated solubility of poorly water-soluble actives through reduction of the dielectric constant of the mixed solvent; the effect is non-linear, with a step change in solubility often occurring between 20% and 40% w/w propylene glycol depending on the solute log P and hydrogen-bonding capacity. For a poorly soluble active with log P near 3.5, a co-solvent system containing 20% w/w propylene glycol and 10% w/w ethanol in purified water may increase solubility by one to two orders of magnitude relative to water alone, but the same system can increase osmolality beyond 800 mOsm/kg, which is above the acceptable limit for many neonatal oral liquids. The European Food Safety Authority has established an acceptable daily intake of 25 mg/kg body weight/day for propylene glycol as food additive E 1520; this is not a pharmaceutical limit but provides a conservative reference for oral paediatric formulation intake when regional pharmacopoeial guidance does not specify an exposure cap. Mixing order is critical: propylene glycol should be combined with the active phase before addition of water to avoid local supersaturation and precipitation on vessel walls; in planetary mixers with bottom-sweep agitators operating at 10–30 rpm, the addition rate of water should not exceed 5% of final batch volume per minute when the propylene glycol fraction is ≥15% w/w. Viscosity of propylene glycol at 25°C is approximately 56 mPa·s, but aqueous blends at 10–20% w/w remain below 5 mPa·s, allowing filtration through 0.45 μm polyethersulfone membrane cartridges without excessive pressure drop. The same filtration step is not universally validated for adsorption of preservative hydroxybenzoates onto the membrane; therefore preservative assay should be checked after filtration because published data for this specific configuration is limited.

When Propylene Glycol Replaces Glycerin in Softgel Shell Plasticizer Systems

Replacing glycerin with propylene glycol in softgel shell formulations changes the gel mass rheology, equilibrium moisture content, seal temperature, and long-term crosslinking behaviour of the gelatin shell. In rotary die encapsulation, the wet gel mass is extruded through a spreader box at 50–70°C and must maintain a viscosity between 20,000 and 45,000 mPa·s at the spreader box shear rate; propylene glycol-plasticized gel masses generally exhibit lower viscosity than glycerin-plasticized masses at equivalent plasticizer-to-gelatin weight ratios, which permits a lower spreader box temperature but reduces ribbon strength if the ratio falls below 0.4:1. A typical replacement formula uses propylene glycol at 10–25% of the dry shell weight, with gelatin at 40–50% and purified water at 35–40% before drying; the higher hygroscopicity of propylene glycol compared with glycerin means that dried shells may reach equilibrium moisture of 6–10% at 25°C and 40% RH, whereas glycerin shells in the same environment often equilibrate closer to 8–12%. Sealing temperature for propylene glycol shells is typically 35–45°C at the die roll nip, and seal integrity is assessed by burst strength using a texture analyser with a spherical probe; minimum burst strength values of 8–12 N are expected for oval softgels of 10 minims fill volume but must be justified for each formulation and die geometry. Because propylene glycol migrates into the fill and from the fill into the shell over time, formulations with high propylene glycol in both shell and fill can approach equilibrium faster, but the migration kinetics follow Fickian diffusion and are accelerated at storage temperatures above 30°C. The incompatibility to control is gelatin crosslinking induced by aldehydes in propylene glycol or by low-molecular-weight oxidation products; crosslinked shells show poor dissolution in USP <711> apparatus 2 at 50 rpm with 900 mL of purified water because the shell remains as a swollen insoluble membrane. Softgel manufacturers should therefore source only monograph-grade propylene glycol with aldehyde and peroxide limits controlled in the site specification and should re-test after long storage at high relative humidity before use.

If Ethylene Glycol and Diethylene Glycol Are Detected Above Pharmacopoeial Limits

If incoming propylene glycol fails the ethylene glycol or diethylene glycol test at a threshold above 0.1%, the material must be hard-quarantined, the lot must not be blended with conforming material, and a formal adulteration investigation should be initiated under 21 CFR 211.84 and 21 CFR 211.94. Diethylene glycol is a potent nephrotoxic and neurotoxic contaminant that has caused fatal poisoning when substituted for glycerin or propylene glycol in oral liquid formulations; the pharmacopoeial limit of ≤0.1% for each contaminant is therefore a safety-critical release specification, not a routine impurity limit. Confirmatory testing should use a second independent method, such as gas chromatography with mass spectrometry or liquid chromatography-tandem mass spectrometry, because co-elution of propylene glycol, ethylene glycol, and diethylene glycol in simple GC-FID methods can mask low-level contamination if the column polarity, inlet temperature, or injection split ratio is incorrectly set. Direct injection of undiluted propylene glycol can overload the column and produce peak tailing that obscures diethylene glycol at 0.05–0.1%; a dilute solution in methanol at approximately 1% w/w with an inlet temperature of 220°C and split ratio of 50:1 improves resolution on a polyethylene glycol capillary column of 30 m × 0.32 mm × 0.5 μm film thickness. The same supply-chain risk applies to recovered or redistilled propylene glycol, which may be offered at lower cost but can concentrate diethylene glycol if distillation was not designed with an appropriate reflux ratio. Supplier audits should include review of ethylene glycol and diethylene glycol test data, gas chromatograph calibration against USP Reference Standards, and the transport vessel cleaning log; a single conforming certificate is insufficient for release because past adulteration incidents have involved fraudulent certificates.

Topical pharmaceutical manufacturing imposes a different set of selection criteria because propylene glycol remains in the finished semisolid at concentrations of 5–15% w/w in creams and gels, 10–50% w/w in medicated lotions, and 10–30% w/w in dermatological solutions. In these products, propylene glycol acts as a humectant, co-solvent for poorly soluble actives, and penetration enhancer that increases stratum corneum permeability by perturbing lipid bilayers and altering the apparent partition coefficient of the drug. The penetration-enhancement effect is concentration-dependent and can increase flux by a factor of 2–10 for selected corticosteroids in in vitro Franz diffusion cell studies using human epidermis according to OECD Test Guideline 428. This same effect creates a safety boundary: topical formulations containing propylene glycol above 20% w/w are associated with an increased incidence of irritant contact dermatitis in sensitive patients, particularly when the product pH is below 4.0 or above 9.0. Manufacturing of oil-in-water creams with propylene glycol in the aqueous phase uses a vacuum emulsifier equipped with an anchor stirrer and a concentric counter-rotating paddle operating at 10–50 rpm, with the aqueous phase heated to 70–75°C and the oil phase heated to 75–80°C before mixing. Propylene glycol should be added to the water phase before the addition of hydrophilic polymers to avoid local gelling of carbomer, and the pH should be adjusted with triethanolamine or sodium hydroxide after the emulsion has cooled to below 40°C; addition of alkali while the emulsion is hot can hydrolyse the propylene glycol esters of fatty acids and raise the free fatty acid content at the oil-water interface, leading to creaming or phase inversion. Preservative efficacy of the finished topical product should be confirmed by USP <51> because propylene glycol can alter the partitioning of preservatives between the water and oil phases and may reduce the free concentration of hydroxybenzoates.

Equipment-Specific Handling, Filtration, and Deaeration in Closed Process Vessels

Propylene glycol is transferred from bulk storage to compounding vessels through 316L stainless steel or polypropylene-lined transfer lines, and the selection of transfer pump must account for its viscosity of 56 mPa·s at 25°C, which increases to approximately 300–400 mPa·s at 0°C and decreases to approximately 12 mPa·s at 50°C. Positive-displacement pumps such as rotary lobe or eccentric disc pumps are preferred over centrifugal pumps for transfers of cold propylene glycol because they maintain flow rates of 500–2000 L/h without excessive shear; shear heating in centrifugal pumps can exceed 5°C at low flow and introduce oxidation risk. Filtration of bulk propylene glycol is typically performed through 0.45 μm or 0.22 μm polyethersulfone or polypropylene filter cartridges, but filter compatibility must be tested because propylene glycol can extract low-molecular-weight oligomers from certain polyvinyl chloride tubing and some elastomeric seals; silicone and EPDM gaskets are generally suitable, whereas natural rubber should be avoided due to swelling and particulate shedding. Deaeration is required for aqueous oral solutions containing propylene glycol and dissolved oxygen above 0.5 mg/L; a common method is vacuum deaeration in a stirred vessel at −0.6 to −0.8 bar for 20–40 minutes after all liquids are combined, followed by nitrogen overlay at 0.2 bar. The same deaeration step can strip volatile actives or preservatives, so it is not appropriate for formulations containing ethanol or benzyl alcohol unless the loss has been quantified by gas chromatography. Clean-in-place systems for propylene glycol residues require hot water at 70–85°C and a detergent with caustic concentration of 1–2% w/w, followed by rinse water until conductivity of the final rinse is below 5 μS/cm. When the same equipment is used for aqueous and anhydrous products, residual water after cleaning can dilute propylene glycol and cause a batch release failure for water content; therefore drying via hot air at 80–90°C for 30–40 minutes is specified before anhydrous batches.